best performing stocks small cap in february 2024

Janux Therapeutics (JANX) had the highest return in February 2024 by a small-cap US stock, returning 456.1%.

ASSETMONTH% RETURN
Janux Therapeutics (JANX)
February 2024
456.09%
SoundHound AI (SOUN)
February 2024
336.47%
Root (ROOT)
February 2024
290.16%
Monopar Therapeutics (MNPR)
February 2024
147.02%
Gaotu Techedu Inc DRC (GOTU)
February 2024
132.74%
GeneDx (WGS)
February 2024
111.69%
Jumia Technologies (JMIA)
February 2024
108.56%
CleanSpark (CLSK)
February 2024
106.42%
Taysha Gene Therapies  (TSHA)
February 2024
104.53%
BigBearai (BBAI)
February 2024
103.64%
Ocular Therapeutix (OCUL)
February 2024
103.23%
Larimar Therapeutics (LRMR)
February 2024
102.11%
Trevi Therapeutics (TRVI)
February 2024
100%
Sana Biotechnology (SANA)
February 2024
82.88%
C4 Therapeutics  (CCCC)
February 2024
74.56%
Hyliion (HYLN)
February 2024
73.33%
Spire Global (SPIR)
February 2024
73.18%
Entera Bio (ENTX)
February 2024
69.75%
PepGen (PEPG)
February 2024
68.82%
Inovio Pharmaceuticals (INO)
February 2024
63.17%
4D Molecular Therapeutics  (FDMT)
February 2024
61.97%
MediaAlpha (MAX)
February 2024
61.23%
Surrozen (SRZN)
February 2024
60.49%
CytomX Therapeutics (CTMX)
February 2024
60.13%
Stoke Therapeutics (STOK)
February 2024
59.59%
Small-cap stocks are treated as having a market cap between $300M and $2B.